697 related articles for article (PubMed ID: 21784348)
1. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup.
Sperling RA; Jack CR; Black SE; Frosch MP; Greenberg SM; Hyman BT; Scheltens P; Carrillo MC; Thies W; Bednar MM; Black RS; Brashear HR; Grundman M; Siemers ER; Feldman HH; Schindler RJ
Alzheimers Dement; 2011 Jul; 7(4):367-85. PubMed ID: 21784348
[TBL] [Abstract][Full Text] [Related]
2. MR imaging features of amyloid-related imaging abnormalities.
Barakos J; Sperling R; Salloway S; Jack C; Gass A; Fiebach JB; Tampieri D; Melançon D; Miaux Y; Rippon G; Black R; Lu Y; Brashear HR; Arrighi HM; Morris KA; Grundman M
AJNR Am J Neuroradiol; 2013 Oct; 34(10):1958-65. PubMed ID: 23578674
[TBL] [Abstract][Full Text] [Related]
3. Detection and Management of Amyloid-Related Imaging Abnormalities in Patients with Alzheimer's Disease Treated with Anti-Amyloid Beta Therapy.
Barakos J; Purcell D; Suhy J; Chalkias S; Burkett P; Marsica Grassi C; Castrillo-Viguera C; Rubino I; Vijverberg E
J Prev Alzheimers Dis; 2022; 9(2):211-220. PubMed ID: 35542992
[TBL] [Abstract][Full Text] [Related]
4. The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer's patients: An interobserver study.
Martens RM; Bechten A; Ingala S; van Schijndel RA; Machado VB; de Jong MC; Sanchez E; Purcell D; Arrighi MH; Brashear RH; Wattjes MP; Barkhof F
Eur Radiol; 2018 Mar; 28(3):1215-1226. PubMed ID: 28956123
[TBL] [Abstract][Full Text] [Related]
5. Chronic Verubecestat Treatment Suppresses Amyloid Accumulation in Advanced Aged Tg2576-AβPPswe Mice Without Inducing Microhemorrhage.
Villarreal S; Zhao F; Hyde LA; Holder D; Forest T; Sondey M; Chen X; Sur C; Parker EM; Kennedy ME
J Alzheimers Dis; 2017; 59(4):1393-1413. PubMed ID: 28800329
[TBL] [Abstract][Full Text] [Related]
6. Amyloid-Related Imaging Abnormalities and β-Amyloid-Targeting Antibodies: A Systematic Review.
Filippi M; Cecchetti G; Spinelli EG; Vezzulli P; Falini A; Agosta F
JAMA Neurol; 2022 Mar; 79(3):291-304. PubMed ID: 35099507
[TBL] [Abstract][Full Text] [Related]
7. Amyloid-related imaging abnormalities-haemosiderin (ARIA-H) in patients with Alzheimer's disease treated with bapineuzumab: a historical, prospective secondary analysis.
Arrighi HM; Barakos J; Barkhof F; Tampieri D; Jack C; Melançon D; Morris K; Ketter N; Liu E; Brashear HR
J Neurol Neurosurg Psychiatry; 2016 Jan; 87(1):106-12. PubMed ID: 25669746
[TBL] [Abstract][Full Text] [Related]
8. Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer's Disease Patients.
Ketter N; Brashear HR; Bogert J; Di J; Miaux Y; Gass A; Purcell DD; Barkhof F; Arrighi HM
J Alzheimers Dis; 2017; 57(2):557-573. PubMed ID: 28269765
[TBL] [Abstract][Full Text] [Related]
9. Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics.
Hampel H; Elhage A; Cho M; Apostolova LG; Nicoll JAR; Atri A
Brain; 2023 Nov; 146(11):4414-4424. PubMed ID: 37280110
[TBL] [Abstract][Full Text] [Related]
10. Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis.
Sperling R; Salloway S; Brooks DJ; Tampieri D; Barakos J; Fox NC; Raskind M; Sabbagh M; Honig LS; Porsteinsson AP; Lieberburg I; Arrighi HM; Morris KA; Lu Y; Liu E; Gregg KM; Brashear HR; Kinney GG; Black R; Grundman M
Lancet Neurol; 2012 Mar; 11(3):241-9. PubMed ID: 22305802
[TBL] [Abstract][Full Text] [Related]
11. Identifying Genetic Risk for Amyloid-Related Imaging Abnormalities.
Hardy J; Schott JM
Neurology; 2024 Feb; 102(3):e208096. PubMed ID: 38165303
[TBL] [Abstract][Full Text] [Related]
12. Imaging of Amyloid-Related Imaging Abnormalities (ARIA).
Urbach H; Linn J; Hattingen E; Fiebach J
Rofo; 2024 Apr; 196(4):363-369. PubMed ID: 37995736
[TBL] [Abstract][Full Text] [Related]
13. Subcortical signal alteration of corticospinal tracts. A radiologic manifestation of ARIA: A case report.
Sotoudeh H; Alizadeh M; Shahidi R; Shobeiri P; Love N; Singhal A
Radiol Case Rep; 2023 Jan; 18(1):275-279. PubMed ID: 36388611
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous ARIA (amyloid-related imaging abnormalities) and cerebral amyloid angiopathy related inflammation in presenilin 1-associated familial Alzheimer's disease.
Ryan NS; Lashley T; Revesz T; Dantu K; Fox NC; Morris HR
J Alzheimers Dis; 2015; 44(4):1069-74. PubMed ID: 25408217
[TBL] [Abstract][Full Text] [Related]
15. Artificial Intelligence Assistive Software Tool for Automated Detection and Quantification of Amyloid-Related Imaging Abnormalities.
Sima DM; Phan TV; Van Eyndhoven S; Vercruyssen S; Magalhães R; Liseune A; Brys A; Frenyo P; Terzopoulos V; Maes C; Guo J; Hughes R; Gabr RE; Huijbers W; Saha-Chaudhuri P; Curiale GG; Becker A; Belachew S; Van Hecke W; Ribbens A; Smeets D
JAMA Netw Open; 2024 Feb; 7(2):e2355800. PubMed ID: 38345816
[TBL] [Abstract][Full Text] [Related]
16. Validation of an MRI Rating Scale for Amyloid-Related Imaging Abnormalities.
Bechten A; Wattjes MP; Purcell DD; Aliaga ES; Daams M; Brashear HR; Arrighi HM; Barkhof F
J Neuroimaging; 2017 May; 27(3):318-325. PubMed ID: 28102639
[TBL] [Abstract][Full Text] [Related]
17. An MRI rating scale for amyloid-related imaging abnormalities with edema or effusion.
Barkhof F; Daams M; Scheltens P; Brashear HR; Arrighi HM; Bechten A; Morris K; McGovern M; Wattjes MP
AJNR Am J Neuroradiol; 2013 Aug; 34(8):1550-5. PubMed ID: 23436056
[TBL] [Abstract][Full Text] [Related]
18. Amyloid-Related Imaging Abnormalities: An Update.
Roytman M; Mashriqi F; Al-Tawil K; Schulz PE; Zaharchuk G; Benzinger TLS; Franceschi AM
AJR Am J Roentgenol; 2023 Apr; 220(4):562-574. PubMed ID: 36321981
[TBL] [Abstract][Full Text] [Related]
19. Amyloid-related imaging abnormalities from trials of solanezumab for Alzheimer's disease.
Carlson C; Siemers E; Hake A; Case M; Hayduk R; Suhy J; Oh J; Barakos J
Alzheimers Dement (Amst); 2016; 2():75-85. PubMed ID: 27239538
[TBL] [Abstract][Full Text] [Related]
20. Vascular alterations in PDAPP mice after anti-Aβ immunotherapy: Implications for amyloid-related imaging abnormalities.
Zago W; Schroeter S; Guido T; Khan K; Seubert P; Yednock T; Schenk D; Gregg KM; Games D; Bard F; Kinney GG
Alzheimers Dement; 2013 Oct; 9(5 Suppl):S105-15. PubMed ID: 23583235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
